These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1811460

  • 1. [Effect of a controlled low-protein diet on the pharmacological response to levodopa and on the plasma levels of L-dopa and amino acids in patients with Parkinson's disease].
    Sanchís G, Mena MA, Martín del Río R, Morales B, Casarejo MJ, de Yébenes MJ, Tabernero C, Jiménez A, de Yébenes JG.
    Arch Neurobiol (Madr); 1991; 54(6):296-302. PubMed ID: 1811460
    [Abstract] [Full Text] [Related]

  • 2. Dietary method for reducing fluctuations in Parkinson's disease.
    Pincus JH, Barry KM.
    Yale J Biol Med; 1987; 60(2):133-7. PubMed ID: 3577210
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.
    Müller T, Kuhn W.
    Mov Disord; 2009 Jul 15; 24(9):1339-43. PubMed ID: 19425084
    [Abstract] [Full Text] [Related]

  • 6. The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease.
    Simon N, Gantcheva R, Bruguerolle B, Viallet F.
    Parkinsonism Relat Disord; 2004 Mar 15; 10(3):137-42. PubMed ID: 15036167
    [Abstract] [Full Text] [Related]

  • 7. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].
    García de Yébenes J, Mateo D, Pino MA, Cordero M, Pastor M, Chacón J, Morales B, Sánchez V, Mena MA, Giménez Roldán S.
    Neurologia; 1997 Apr 15; 12(4):145-56. PubMed ID: 9235023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dietary factors in the management of Parkinson's disease.
    Kempster PA, Wahlqvist ML.
    Nutr Rev; 1994 Feb 15; 52(2 Pt 1):51-8. PubMed ID: 8183469
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep 15; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M, Nouzeilles MI, Arce GP, Leiguarda R.
    Mov Disord; 2002 Jul 15; 17(4):795-8. PubMed ID: 12210878
    [Abstract] [Full Text] [Related]

  • 19. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
    Rascol O, Brooks DJ, Brunt ER, Korczyn AD, Poewe WH, Stocchi F.
    Mov Disord; 1998 Jan 15; 13(1):39-45. PubMed ID: 9452324
    [Abstract] [Full Text] [Related]

  • 20. Clinical and pharmacological differences in early- versus late-onset Parkinson's disease.
    Gomez Arevalo G, Jorge R, Garcia S, Scipioni O, Gershanik O.
    Mov Disord; 1997 May 15; 12(3):277-84. PubMed ID: 9159719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.